Patents by Inventor Pin-Yi Wu

Pin-Yi Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIQUID LEAKAGE DETECTING MODULE AND LIQUID LEAKAGE DETECTING DEVICE
    Publication number: 20240085262
    Abstract: A liquid leakage detecting module includes a liquid leakage detecting device, a monitoring device and a main wire. The liquid leakage detecting device includes a hub and a plurality of liquid leakage detection branches electrically connected to the hub in parallel. The hub is electrically connected to the monitoring device though the main wire.
    Type: Application
    Filed: November 11, 2022
    Publication date: March 14, 2024
    Inventors: JIANG-JUN WU, PIN-YI XIANG
  • Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
    Patent number: 7320791
    Abstract: A novel anti-polyethylene glycol monoclonal antibody and its preparation are disclosed. Such an antibody can be used for determining polyethylene glycol concentration in vitro or accelerating the clearance of a polyethylene glycol containing compound from the blood circulation in the human body thereby reducing the toxicity associated with the polyethylene glycol containing conjugate. The antibody is particularly useful in cancer therapy where the therapeutic agent is selectively delivered to the tumor by increasing the tumor/blood ratio of the polyethylene glycol containing compound.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: January 22, 2008
    Assignee: Academia Sinica
    Inventors: Steve Roffler, Tian-Lu Cheng, Pin-Yi Wu
  • Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
    Publication number: 20040014156
    Abstract: A novel anti-polyethylene glycol monoclonal antibody and its preparation are disclosed. Such an antibody can be used for determining polyethylene glycol concentration in vitro or accelerating the clearance of a polyethylene glycol containing compound from the blood circulation in the human body thereby reducing the toxicity associated with the polyethylene glycol containing conjugate. The antibody is particularly useful in cancer therapy where the therapeutic agent is selectively delivered to the tumor by increasing the tumor/blood ratio of the polyethylene glycol containing compound.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 22, 2004
    Applicant: Academia Sinica
    Inventors: Steve Roffler, Tian-Lu Cheng, Pin-Yi Wu
  • Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
    Patent number: 6617118
    Abstract: A novel anti-polyethylene glycol monoclonal antibody and its preparation are disclosed. Such an antibody can be used for determining polyethylene glycol concentration in vitro or accelerating the clearance of a polyethylene glycol containing compound from the blood circulation in the human body thereby reducing the toxicity associated with the polyethylene glycol containing conjugate. The antibody is particularly useful in cancer therapy where the therapeutic agent is selectively delivered to the tumor by increasing the tumor/blood ratio of the polyethylene glycol containing compound.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: September 9, 2003
    Assignee: Academia Sinica
    Inventors: Steve Roffler, Tian-Lu Cheng, Pin-Yi Wu
  • Monoclonal-antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
    Patent number: 6596849
    Abstract: A novel anti-polyethylene glycol monoclonal antibody and its preparation are disclosed. Such an antibody can be used for determining polyethylene glycol concentration in vitro or accelerating the clearance of a polyethylene glycol containing compound from the blood circulation in the human body thereby reducing the toxicity associated with the polyethylene glycol containing conjugate. The antibody is particularly useful in cancer therapy where the therapeutic agent is selectively delivered to the tumor by increasing the tumor/blood ratio of the polyethylene glycol containing compound.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: July 22, 2003
    Assignee: Academia Sinica
    Inventors: Steve Roffler, Tian-Lu Cheng, Pin-Yi Wu
  • Monoclonal antibody for analysis and clearance of polyethylene glycol and polyethylene glycol-modified molecules
    Publication number: 20010028881
    Abstract: A novel anti-polyethylene glycol monoclonal antibody and its preparation are disclosed. Such an antibody can be used for determining polyethylene glycol concentration in vitro or accelerating the clearance of a polyethylene glycol containing compound from the blood circulation in the human body thereby reducing the toxicity associated with the polyethylene glycol containing conjugate. The antibody is particularly useful in cancer therapy where the therapeutic agent is selectively delivered to the tumor by increasing the tumor/blood ratio of the polyethylene glycol containing compound.
    Type: Application
    Filed: March 16, 2001
    Publication date: October 11, 2001
    Applicant: Academia Sinica
    Inventors: Steve Roffler, Tian-Lu Cheng, Pin Yi Wu